Clinicopathologic factors related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer An analysis of 2050 patients

被引:28
|
作者
Lai, Hung-Wen [1 ,2 ,3 ,4 ,6 ,11 ,12 ]
Huang, Ren-Hung [5 ,12 ]
Wu, Yu-Ting [10 ,14 ]
Chen, Chih-Jung [5 ,6 ,12 ]
Chen, Shou-Tung [1 ,2 ,3 ,12 ]
Lin, Ying-Jen [7 ,12 ]
Chen, Dar-Ren [1 ,2 ,3 ,12 ]
Lee, Chih-Wei [8 ,12 ]
Wu, Hwa-Koon [8 ,12 ]
Lin, Hui-Yu [9 ,13 ]
Kuo, Shou-Jen [2 ,3 ,12 ]
机构
[1] Changhua Christian Hosp, Endoscop & Oncoplast Breast Surg Ctr, Changhua, Taiwan
[2] Changhua Christian Hosp, Comprehens Breast Canc Ctr, 135 Nanxiao St, Changhua 500, Taiwan
[3] Changhua Christian Hosp, Dept Surg, Div Gen Surg, Changhua, Taiwan
[4] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[5] Changhua Christian Hosp, Dept Surg Pathol, Changhua, Taiwan
[6] Chung Shan Med Univ, Sch Med, Taichung, Taiwan
[7] Changhua Christian Hosp, Tumor Ctr, Changhua, Taiwan
[8] Changhua Christian Hosp, Dept Radiol, Changhua, Taiwan
[9] Cardinal Tien Hosp, Breast Surg Ctr, Dept Surg, Div Gen Surg, Taipei, Taiwan
[10] Wuri Lin Shin Hosp, Dept Surg, Taichung, Taiwan
[11] Kaohsiung Med Univ, Kaohsiung, Taiwan
[12] 135 Nanxiao St, Changhua 500, Taiwan
[13] 362 Zhongzheng Rd, New Taipei 23148, Taiwan
[14] 168 Ronghe Rd, Taichung 414, Taiwan
来源
EJSO | 2018年 / 44卷 / 11期
关键词
Breast cancer; Surgical margin; Magnetic resonance imaging (MRI); Breast-conserving surgery (BCS); Mastectomy; Ductal carcinoma in situ; CONSERVING SURGERY; POSITIVE MARGINS; RE-EXCISION; LOCAL RECURRENCE; LOBULAR CARCINOMA; ADEQUATE MARGIN; TUMOR SIZE; REEXCISION; LUMPECTOMY; BIOPSY;
D O I
10.1016/j.ejso.2018.07.056
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: To evaluate whether clinicopathologic factors are related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer. Methods: Identification of patients at increased risk for positive surgical margins may enhance clinical preoperative decision-making and lower the reoperation rate. In this retrospective study, we analyzed the factors associated with positive surgical margins, the need for re-excision, and residual cancer detection in re-excised specimens in a cohort of 2050 women who underwent either breast-conserving surgery (BCS) or mastectomy for primary operable breast cancer. Results: Positive surgical margins were detected in 151 (7.4%) of the 2050 patients. The incidence of positive surgical margins was 11.3% (118/1042) in the BCS group and 33% (33/1008) in the mastectomy group (P < 0.001). In multivariate analysis, lower body mass index (BMI), larger tumor size, and pathologic evidence of multifocal disease were associated with positive surgical margin involvement in the BCS group. Younger age and ductal carcinoma in situ (DCIS) histologic subtypes (Odds ratio (OR) = 2.165, 95% CI = 1.253-4323) were associated with higher risk of re-operations. Preoperative MRI examination was associated with decreased risk for margin involvement in the BCS group (OR = 0.530, 95% CI = 0.332-0.842) and reoperation (OR = 0.302, 95% CI = 0.119-0.728). DCIS histologic subtypes were associated with higher residual tumor incidence than other types of breast cancer. Conclusions: Lower BMI, larger tumor size, pathologic evidence of multifocal disease, and no preoperative MRI evaluation were associated with increased risk for positive surgical margin involvement. DCISwith positive surgical margins was associated with increased risk for reoperation and residual cancer detection at re-excision. (C) 2018 Elsevier Ltd, BASO similar to The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.
引用
收藏
页码:1725 / 1735
页数:11
相关论文
共 50 条
  • [1] Clinicopathologic factors related to surgical margin involvement, reoperation, and residual breast cancer in primary operable breast cancer - An analysis of 2050 patients
    Lai, H-W
    Chen, S-T
    Chen, D-R
    CANCER RESEARCH, 2017, 77
  • [2] Clinicopathologic factors related to margin involvement, reoperation, and residual breast cancer in primary operable breast cancer
    Lai, H. -W.
    Chen, S. -T.
    Chen, D. -R.
    ANNALS OF ONCOLOGY, 2015, 26 : 24 - 24
  • [3] Clinicopathologic factors associated with surgical margins in primary invasive breast cancer
    Kumar, Anupama Praveen
    Vicente, Diego
    Kumar, Praveen Kumar Raj
    Liu, Jianfang
    Deyarmin, Brenda
    Mostoller, Brad
    Kovatich, Albert J.
    Hooke, Jeffrey A.
    Fantacone-Campbell, Leigh
    Lin, Xiaoying
    Shriver, Craig D.
    Hu, Hai
    CANCER RESEARCH, 2022, 82 (12)
  • [4] The Usefulness of Spectral Mammography in Surgical Planning of Breast Cancer Treatment-Analysis of 999 Patients with Primary Operable Breast Cancer
    Lorek, Andrzej
    Steinhof-Radwanska, Katarzyna
    Barczyk-Gutkowska, Anna
    Zarebski, Wojciech
    Palen, Piotr
    Szyluk, Karol
    Lorek, Joanna
    Grazynska, Anna
    Niemiec, Pawel
    Gisterek, Iwona
    CURRENT ONCOLOGY, 2021, 28 (04) : 2548 - 2559
  • [5] Predictors of surgical margin involvement in breast cancer surgery
    Goikoetxea Urdiain, A.
    Eguaras Cordoba, I.
    Otegi Altolagirre, I.
    Moras Perez, N.
    Sanz de Pablo, M. A.
    Artieda Soto, C.
    Armendariz Rubio, P.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S24 - S24
  • [6] Clinicopathologic Characteristics and Prognostic Factors in Patients with Operable HER-2 Overexpressing Breast Cancer
    Liu, Ai-Na
    Sun, Ping
    Liu, Jian-Nan
    Ma, Jin-Bo
    Qu, Hua-Jun
    Zhu, Hua
    Yu, Cai-Yan
    Zhang, Liang-Ming
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (04) : 1197 - 1201
  • [7] Clinicopathologic characteristics of gastric cancer patients with cancer infiltration at surgical margin at gastrectomy
    Fujimoto, S
    Takahashi, M
    Mutou, T
    Kobayashi, K
    Toyosawa, T
    Ohkubo, H
    ANTICANCER RESEARCH, 1997, 17 (1B) : 689 - 694
  • [8] Factors predictive of response to primary chemotherapy for operable breast cancer
    Colleoni, M
    Orvieto, E
    Nole, F
    Orlando, L
    Viale, G
    Peruzzotti, G
    Sacchini, V
    Veronesi, P
    Orecchia, R
    Goldhirsch, A
    ANNALS OF ONCOLOGY, 1998, 9 : 6 - 7
  • [9] Prognostic value of residual node involvement in operable breast cancer after induction chemotherapy
    Curé, H
    Amat, S
    Penault-Llorca, F
    le Bouëdec, G
    Ferrière, JP
    Mouret-Reynier, MA
    Kwiatkowski, F
    Feillel, V
    Dauplat, J
    Chollet, P
    BREAST CANCER RESEARCH AND TREATMENT, 2002, 76 (01) : 37 - 45
  • [10] Prognostic Value of Residual Node Involvement in Operable Breast Cancer after Induction Chemotherapy
    Hervé Curé
    Sophie Amat
    Frédérique Penault-Llorca
    Guillaume le Bouëdec
    Jean-Pierre Ferrière
    Marie-Ange Mouret-Reynier
    Fabrice Kwiatkowski
    Viviane Feillel
    Jacques Dauplat
    Philippe Chollet
    Breast Cancer Research and Treatment, 2002, 76 : 37 - 45